Aspirin’s use in primary prevention has narrowed sharply in recent years, but new findings suggested an important new role: reducing risk for aortic stenosis in people with elevated lipoprotein(a) (Lp ...

Liftoff of the "Insight at Speed is a Friend Indeed" mission occurred at 6:53 p.m. ET today (March 5). When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

Daily aspirin does not reliably prevent bowel cancer in people at average risk, according to a major new review. Any potential protective effect may take more than a decade to appear — if it appears ...

Doctors have long recommended daily aspirin for years as a low-cost protection against cancers of the lower bowel. New research suggests there might not be a dependable benefit for low-risk patients.

Daily aspirin use does not offer a quick or reliable way to prevent bowel cancer in the general population and carries immediate risks of serious bleeding, a new Cochrane review finds. Bowel cancer, ...

A new study has ignited the debate over whether every pregnant woman should take low-dose aspirin. Aspirin is cheap, widely available and generally safe, which makes it tempting to give it to everyone ...

We preselected all newsletters you had before unsubscribing.

Share on Pinterest A follow-up study indicates that aspirin should not be recommended to older adults for cancer prevention. Image credit: Yulia Naumenko/Getty Images A new study suggests that ...

Aspirin shortages in the UK have left some patients wondering what to do if they can’t find it at the pharmacy. If someone turns to an old bottle in the medicine cabinet and notices a faint vinegar ...

Share on Pinterest A new study shows daily aspirin use doesn’t impact cancer incidence but may raise the risk of cancer-related mortality. coldsnowstorm/Getty Images Researchers say that a daily ...

President Donald Trump, in a wide-ranging interview with The Wall Street Journal earlier this month, revealed that he takes a high-dose aspirin pill every day despite his doctors encouraging him to ...

FOxTROT: Predictive effects of ERBB2 and ERBB3 on neoadjuvant panitumumab benefit in RAS/BRAF wild-type (-wt) locally advanced colon cancer (LACC). This is an ASCO Meeting Abstract from the 2026 ASCO ...